Clinical Trial Update: An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia [Phase 2]

View source ↗

Summary

A Phase 2 open-label study evaluating topical FP1198 for pain in cyclic mastalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cyclic Mastalgia

Drugs mentioned

• FP1198

Snippet

Sponsor: FemmePharma Global Healthcare, Inc. | Conditions: Moderate to Severe Cyclic Mastalgia | Phase 2 | Status: COMPLETED